Posizioni attive di Heiko von der Leyen
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORGENESIS INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2020 | - |
Storia della carriera di Heiko von der Leyen
Precedenti posizioni note di Heiko von der Leyen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01/01/2005 | 01/01/2017 |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Direttore Tecnico/Scientifico/R&S | 01/01/2003 | 01/01/2004 |
Artiss GmbH | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | 01/01/2002 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Direttore Tecnico/Scientifico/R&S | 01/01/1998 | 01/01/2001 |
Statistiche
Distribuzione geografica
Germania | 5 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ORGENESIS INC. | Health Technology |
Aziende private | 4 |
---|---|
Hannover Clinical Trial Center GmbH | |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Health Technology |
Artiss GmbH | |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Health Technology |
- Borsa valori
- Insiders
- Heiko von der Leyen
- Esperienza